NS040408/NS/NINDS NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2006	1
2008	6
2009	1
2010	3
2011	4
2012	5
2013	3
2014	5
2015	5
2016	3
2017	1
2018	3
2019	2
2020	1
2022	0

1

Complex neuroprotective and neurotoxic effects of histone deacetylases.

Thomas EA, D'Mello SR. Thomas EA, et al. J Neurochem. 2018 Apr;145(2):96-110. doi: 10.1111/jnc.14309. Epub 2018 Apr 6. J Neurochem. 2018. PMID: 29355955 Free PMC article. Review.

2

Epigenetics, autism spectrum, and neurodevelopmental disorders.

Rangasamy S, D'Mello SR, Narayanan V. Rangasamy S, et al. Neurotherapeutics. 2013 Oct;10(4):742-56. doi: 10.1007/s13311-013-0227-0. Neurotherapeutics. 2013. PMID: 24104594 Free PMC article. Review.

3

Insights into the regulation of neuronal viability by nucleophosmin/B23.

Pfister JA, D'Mello SR. Pfister JA, et al. Exp Biol Med (Maywood). 2015 Jun;240(6):774-86. doi: 10.1177/1535370215579168. Epub 2015 Apr 22. Exp Biol Med (Maywood). 2015. PMID: 25908633 Free PMC article. Review.

4

Histone deacetylases 1, 2 and 3 in nervous system development.

D'Mello SR. D'Mello SR. Curr Opin Pharmacol. 2020 Feb;50:74-81. doi: 10.1016/j.coph.2019.11.007. Epub 2020 Jan 2. Curr Opin Pharmacol. 2020. PMID: 31901696 Review.

5

Regulation of Central Nervous System Development by Class I Histone Deacetylases.

D'Mello SR. D'Mello SR. Dev Neurosci. 2019;41(3-4):149-165. doi: 10.1159/000505535. Epub 2020 Jan 24. Dev Neurosci. 2019. PMID: 31982872 Free PMC article. Review.

6

Class IIA HDACs in the regulation of neurodegeneration.

Majdzadeh N, Morrison BE, D'Mello SR. Majdzadeh N, et al. Front Biosci. 2008 Jan 1;13:1072-82. doi: 10.2741/2745. Front Biosci. 2008. PMID: 17981613 Free PMC article. Review.

7

Catalytic-independent neuroprotection by SIRT1 is mediated through interaction with HDAC1.

Pfister JA, Ma C, D'Mello SR. Pfister JA, et al. PLoS One. 2019 Apr 11;14(4):e0215208. doi: 10.1371/journal.pone.0215208. eCollection 2019. PLoS One. 2019. PMID: 30973934 Free PMC article.

8

Histone deacetylases as targets for the treatment of human neurodegenerative diseases.

D'Mello SR. D'Mello SR. Drug News Perspect. 2009 Nov;22(9):513-24. doi: 10.1358/dnp.2009.9.1428871. Drug News Perspect. 2009. PMID: 20072728 Free PMC article. Review.

9

Proteomic analysis identifies NPTX1 and HIP1R as potential targets of histone deacetylase-3-mediated neurodegeneration.

Qu Z, D'Mello SR. Qu Z, et al. Exp Biol Med (Maywood). 2018 Apr;243(7):627-638. doi: 10.1177/1535370218761149. Epub 2018 Feb 27. Exp Biol Med (Maywood). 2018. PMID: 29486577 Free PMC article.

10

Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.

Louis Sam Titus ASC, Yusuff T, Cassar M, Thomas E, Kretzschmar D, D'Mello SR. Louis Sam Titus ASC, et al. J Neurosci. 2017 Jul 5;37(27):6575-6587. doi: 10.1523/JNEUROSCI.3612-16.2017. Epub 2017 May 26. J Neurosci. 2017. PMID: 28550168 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results